Mondelez International delivered one of its biggest single-session moves in recent memory this week. A strong Q1 earnings print on April 28 sent the stock up roughly 6.3% in a day, pushing a weekly gain to nearly 9% and closing at $61.04 on April 29.
The most telling story this week is what happened to options positioning after that result. The put/call ratio dropped to 1.08 — well below its 20-day average of 1.26 and about 1.8 standard deviations beneath it. That is the least defensive options posture the stock has seen in months: compare it to a reading of 1.74 in late March, which was the highest of the past year. Investors who spent weeks stacking downside protection appear to have unwound a meaningful chunk of it post-print.
Short interest tells a quieter story. At just under 2.8% of the free float, the position is not large enough to represent a real structural short thesis. That said, it has drifted up about 6% week-on-week to roughly 35.3 million shares, retracing much of the decline from early April when it briefly fell below 2.4% of float. The borrow market remains completely unexciting — cost to borrow is 0.49% and availability is loose, leaving no squeeze dynamic in play.
The Street responded to the earnings beat with immediate and widespread upward revisions. Every firm that acted on April 29 raised its price target: JP Morgan's Thomas Palmer lifted to $70 (from $67) while keeping an Overweight; Evercore ISI pushed to $71; Barclays moved to $68; UBS edged to $64 even from its Neutral stance; and TD Cowen raised to $67. The consensus mean target is now $67.12, about 10% above the current price. With 12 buys and the analyst recommendation divergence ranking in the 93rd percentile, the Street is leaning decisively constructive. The bull case centres on category dominance and emerging market exposure as cocoa cost headwinds ease; the bear case focuses on private-label pressure in developed markets and still-compressed near-term margins. The stock's EV/EBITDA of 14.1x has expanded modestly over the past week, consistent with a relief re-rating post-earnings, though the dividend score ranking of 91 and the analyst recommendation percentile suggest the income and quality-focused investor base remains well anchored.
Institutional ownership is broad and stable. Vanguard holds 10.2% of shares, Capital Research 9.4%, and BlackRock 7.9%, with all three adding shares in the March quarter. FMR (Fidelity) was the most active buyer in that period, adding roughly 5.1 million shares. The insider register is less supportive: the most recent transactions were all sells in April and February, including a $3.8 million sale by CEO Dirk Van De Put in February, though at significance scores of 1, these appear routine rather than discretionary.
The next confirmed earnings event is scheduled for May 20. With options hedges largely unwound and short interest back near its April highs on a percentage-of-float basis, the setup heading into that date — and any cocoa-cost commentary in between — is the natural focus for how positioning resets from here.
See the live data behind this article on ORTEX.
Open MDLZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
